IGF2BP1 and neoplasm: Specifically, ALKBH5, ELAVL1, FTO, HNRNPA2B1, IGF2BP1, IGF2BP3, METT10D, METTL14, METTL3, METTL5, WTAP, YTHDC1, YTHDF1, YTHDF2, YTHDF3, and ZC3H13 displayed differential expression in tumor and normal tissues (Figure 1B).